Financial Performance - The company's operating revenue for Q3 2025 was ¥146,604,936.43, representing a year-on-year increase of 34.97%[3] - The total profit for the quarter was ¥22,662,651.04, showing a decrease of 17.94% compared to the same period last year[3] - Net profit attributable to shareholders was ¥23,218,225.61, down 5.98% year-on-year[3] - Total operating revenue for the first three quarters of 2025 reached ¥385,845,103.24, a 31.2% increase from ¥294,041,286.40 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was ¥56,586,865.80, compared to ¥54,627,824.73 in 2024, reflecting a 3.6% increase[19] Assets and Liabilities - The total assets at the end of the reporting period reached ¥1,788,934,867.36, an increase of 19.89% from the end of the previous year[4] - Total liabilities amounted to ¥886,448,664.01, slightly up from ¥886,139,338.63 in 2024, indicating stable financial leverage[16] - The total assets of the company as of the end of the reporting period were ¥1,788,934,867.36, compared to ¥1,492,105,289.02 in the previous year, marking a growth of 19.9%[16] Shareholder Information - The company reported a total of 9,036 common shareholders at the end of the reporting period[10] - The largest shareholder, Li Xiaomin, holds 39.41% of the shares, totaling 158,937,232 shares[10] - The second-largest shareholder, Ningbo Fengnian Rongtong Investment Management, holds 6.22% with 25,071,347 shares[10] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥155,814,159.05, reflecting a slight increase of 0.33%[3] - The cash flow from operating activities for the first three quarters of 2025 was ¥375,254,916.37, compared to ¥296,966,975.33 in 2024, showing a strong cash generation capability[22] - Operating cash inflow totaled $404,639,874.82, an increase from $342,667,241.77 in the previous period, reflecting a growth of approximately 18.1%[23] Research and Development - Research and development expenses totaled ¥14,064,097.85, accounting for 9.59% of operating revenue, a decrease of 0.62 percentage points[4] - Research and development expenses increased to ¥41,023,247.28 in 2025, up from ¥32,643,817.33 in 2024, indicating a focus on innovation[19] Equity - The equity attributable to shareholders increased by 48.93% to ¥902,486,203.35 due to the completion of the initial public offering[8] - The company's equity attributable to shareholders increased to ¥902,486,203.35 from ¥605,965,950.39, representing a significant growth of 48.9%[16] Cash and Cash Equivalents - Cash and cash equivalents rose to ¥133,815,605.65, compared to ¥112,620,868.69 at the end of 2024, indicating an increase of about 18.8%[14] - The total cash and cash equivalents at the end of the period amounted to $133,815,605.65, compared to $111,830,341.13 at the end of the previous period, showing an increase of approximately 19.6%[24] Investment Activities - Net cash outflow from investing activities was -$388,173,960.76, compared to -$332,514,204.00 in the prior period, indicating a decline in investment cash flow[23] - Cash paid for the purchase of fixed assets was $350,838,173.51, slightly down from $353,196,885.67, indicating a decrease of about 0.8%[23] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[25]

Financial Performance - The company's operating revenue for Q3 2025 was ¥254,594,346.51, a decrease of 22.89% compared to the same period last year[3] - The total profit for the period was -¥23,832,752.76, reflecting a decline of 197.72% year-on-year[3] - The net profit attributable to shareholders was -¥11,486,705.49, down 145.55% compared to the previous year[3] - The basic earnings per share for the period was -¥0.08, a decrease of 147.06% year-on-year[3] - The net profit attributable to shareholders for the year-to-date was ¥30,707,129.47, down 66.43% year-on-year[3] - The company reported a decrease in total profit for the year-to-date of 70.34% compared to the previous year[3] - Total operating revenue for the first three quarters of 2025 is CNY 830,923,213.71, a decrease of 16.4% compared to CNY 993,675,118.35 in the same period of 2024[31] - Operating profit for the first three quarters of 2025 is CNY 28,473,843.14, a decline of 70.2% from CNY 95,440,669.03 in the previous year[32] - Net profit for the first three quarters of 2025 is CNY 30,608,489.64, compared to CNY 91,878,179.49 in 2024, representing a decrease of 66.7%[32] - Basic and diluted earnings per share for the first three quarters of 2025 are both CNY 0.21, down from CNY 0.63 in the same period of 2024[33] Assets and Liabilities - The total assets at the end of the period were ¥3,556,986,653.85, a decrease of 9.78% from the previous year[4] - Total assets as of the latest reporting date amount to CNY 3,556,986,653.85, a decrease from CNY 3,942,382,816.71[28] - Total liabilities decreased to CNY 1,863,794,933.31 from CNY 2,252,106,625.29, indicating a reduction of 17.2%[28] - Non-current liabilities increased to CNY 501,755,754.07 from CNY 466,045,436.92, reflecting an increase of 7.7%[28] - Total equity as of the latest reporting date is CNY 1,693,191,720.54, slightly up from CNY 1,690,276,191.42[28] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥218,915,114.81[3] - Cash flow from operating activities for the first three quarters of 2025 is not provided, but the company reported significant changes in net profit and operating costs, indicating potential cash flow challenges[34] - In the first three quarters of 2025, the cash inflow from operating activities was CNY 810,505,470.40, a decrease of 13.6% compared to CNY 938,660,255.80 in the same period of 2024[36] - The net cash flow from operating activities was negative CNY 218,915,114.81 for the first three quarters of 2025, worsening from negative CNY 389,217,083.84 in 2024[36] - The cash outflow from investing activities totaled CNY 107,792,630.28 in 2025, compared to CNY 225,685,933.92 in 2024, resulting in a net cash flow from investing activities of negative CNY 107,789,130.28[37] - Cash inflow from financing activities was CNY 416,971,926.30 in 2025, down from CNY 530,290,657.27 in 2024, with a net cash flow of CNY 91,290,540.36[37] - The ending cash and cash equivalents balance for 2025 was CNY 165,533,303.20, slightly down from CNY 170,584,200.89 in 2024[37] - The company reported a significant increase in cash paid for purchasing goods and services, totaling CNY 714,080,233.77 in 2025, compared to CNY 876,574,104.09 in 2024[36] - The cash received from other operating activities was CNY 64,471,788.54 in 2025, compared to CNY 55,410,695.17 in 2024, indicating a growth of approximately 16.5%[36] - The company experienced a decrease in cash received from sales of goods and services, which was CNY 733,196,422.37 in 2025, down from CNY 883,249,560.63 in 2024, reflecting a decline of about 17%[36] - The company’s cash flow from financing activities included CNY 397,059,693.23 from borrowings in 2025, compared to CNY 480,319,109.58 in 2024, showing a decrease of approximately 17.3%[37] Shareholder Information - The company had a total of 15,637 common shareholders at the end of the reporting period[10] - The top shareholder, Zhang Weiming, holds 60.52% of the shares, significantly influencing company decisions[11] - The company has not identified any related party relationships among the top shareholders, except for the actual controllers[11] - The company has not engaged in any securities lending activities during the reporting period[12] Share Repurchase and Convertible Bonds - The company plans to repurchase shares using between RMB 30 million and RMB 60 million from February 19, 2024, to February 18, 2025[13] - The total share capital after the rights distribution will be 149,462,500 shares, with a capital increase of 0.2 shares per share held[14] - The company completed a share repurchase of 1,205,900 shares, accounting for 0.82% of the total share capital, at an average price of RMB 25.08 per share[15] - The company intends to issue convertible bonds to raise up to RMB 500 million for semiconductor equipment projects and working capital[16] - The company received an inquiry letter from the Shanghai Stock Exchange regarding its application for issuing convertible bonds, which it is addressing[17] - The company adjusted the maximum repurchase price from RMB 41.43 to RMB 34.34 per share following the rights distribution[14] - The company will continue to update financial data in response to regulatory inquiries regarding the convertible bond issuance[18] - The company plans to issue convertible bonds totaling up to RMB 492.8049 million, with adjustments made to the issuance scale and fundraising purposes[19] - On August 8, 2025, the company decided to terminate the issuance of convertible bonds and withdraw the application due to changes in external environment and overall development plans[20] - The company completed the cancellation of 509,000 repurchased shares from 2022, reducing the total share capital from 149,074,060 to 148,565,060 shares[22] - The company plans to repurchase and cancel 750,000 shares from the 2023 employee stock ownership plan at a price of RMB 14.5833 per share plus bank interest[23] - A total of 885,480 shares from the 2023 employee stock ownership plan were canceled, further reducing the total share capital to 147,679,580 shares[25] Accounting Standards - The company did not apply new accounting standards for the year 2025, as indicated in their announcement[38]

公司负责人张海明、主管会计工作负责人王兴春及会计机构负责人（会计主管人员）黄俊芹保证 季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 上海海利生物技术股份有限公司 2025 年第三季度报告 证券代码：603718 证券简称：海利生物 上海海利生物技术股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 39,965,105.06 | -40. ...

Financial Performance - The company's revenue for Q3 2025 reached ¥796,436,734.54, representing a year-on-year increase of 26.15% and a year-to-date increase of 46.04%[3] - Total profit for the quarter was ¥82,917,435.57, up 75.81% year-on-year, while year-to-date profit increased by 128.99% to ¥264,371,253.08[3] - Net profit attributable to shareholders for Q3 was ¥76,016,224.12, reflecting an 85.41% increase compared to the same period last year, and a year-to-date increase of 119.89%[3] - The basic earnings per share for the quarter was ¥0.37, a 42.31% increase year-on-year, with year-to-date earnings per share at ¥1.14, up 70.15%[3] - Total operating revenue for the first three quarters of 2025 reached ¥2,321,243,110.96, a significant increase of 46.0% compared to ¥1,589,446,323.13 in the same period of 2024[18] - Operating profit for the first three quarters of 2025 was ¥265,796,360.86, up 130.0% from ¥115,563,653.59 in the first three quarters of 2024[18] - Net profit attributable to shareholders of the parent company for the first three quarters of 2025 was ¥232,998,297.12, representing a 120.0% increase from ¥105,962,961.63 in the same period of 2024[19] - The company reported a total comprehensive income of ¥239,449,747.78 for the first three quarters of 2025, compared to ¥95,145,489.45 in the same period of 2024, indicating a substantial increase[19] - Basic earnings per share for the first three quarters of 2025 were ¥1.14, up from ¥0.67 in the same period of 2024, reflecting a growth of 70.1%[19] Cash Flow and Liquidity - The company reported a net cash flow from operating activities of ¥17,312,907.30 year-to-date, which is a significant decrease of 89.62% compared to the previous year[3] - The company’s cash flow statement for the first three quarters of 2025 indicates a strong liquidity position, although specific cash flow figures were not provided in the available data[21] - In the first three quarters of 2025, the cash inflow from operating activities reached ¥1,910,043,611.18, a 30% increase from ¥1,469,031,185.20 in the same period of 2024[22] - The net cash flow from operating activities was ¥17,312,907.30, a significant decrease of 89.6% compared to ¥166,750,269.57 in the previous year[22] - Cash inflow from investment activities totaled ¥1,198,233,754.48, up from ¥230,757,803.40 in the first three quarters of 2024[23] - The net cash flow from investment activities was -¥405,892,380.11, an improvement from -¥587,789,791.74 in the same period last year[23] - Cash inflow from financing activities amounted to ¥963,051,284.48, compared to ¥641,468,088.68 in the first three quarters of 2024, marking a 50% increase[23] - The net cash flow from financing activities was ¥287,760,391.07, up from ¥166,138,526.91 in the previous year[23] - The ending balance of cash and cash equivalents was ¥860,580,654.51, an increase from ¥656,835,327.55 at the end of the same period last year[23] - The company received ¥8,782,166.99 from investment contributions, which is a 149% increase from ¥3,527,622.21 in the previous year[23] - The total cash outflow from investment activities was ¥1,604,126,134.59, compared to ¥818,547,595.14 in the same period of 2024[23] - The company reported a cash outflow of ¥501,987,997.33 for debt repayment, which increased from ¥317,354,557.70 in the previous year[23] Assets and Liabilities - The company has seen a 9.03% increase in total assets year-on-year, reaching ¥4,711,437,358.76, and a 9.44% increase in equity attributable to shareholders[4] - Total assets as of September 30, 2025, amounted to RMB 4,711,437,358.76, an increase from RMB 4,321,263,951.75 as of December 31, 2024[13] - Current assets totaled RMB 3,227,715,194.43, up from RMB 3,013,865,135.28 in the previous period, reflecting a growth of approximately 7.1%[13] - Cash and cash equivalents decreased to RMB 900,784,368.38 from RMB 1,015,471,964.72, indicating a decline of about 11.3%[13] - Accounts receivable increased to RMB 925,902,993.50 from RMB 895,747,358.89, showing a rise of approximately 3.1%[13] - Inventory decreased to RMB 544,291,032.51 from RMB 607,192,981.77, representing a decline of about 10.4%[13] - Total liabilities as of September 30, 2025, were RMB 2,827,715,194.43, compared to RMB 2,713,865,135.28 previously, reflecting an increase of approximately 4.1%[14] - Short-term borrowings increased to RMB 498,343,245.51 from RMB 466,230,744.41, indicating a rise of about 6.0%[14] - Accounts payable decreased to RMB 821,982,019.48 from RMB 973,479,420.15, showing a decline of approximately 15.6%[14] - The total liabilities increased to ¥2,376,125,435.28 in 2025 from ¥2,189,517,280.62 in 2024, reflecting a growth of 8.5%[18] - The total equity attributable to shareholders of the parent company rose to ¥2,293,235,904.32 in 2025, compared to ¥2,095,392,838.27 in 2024, marking an increase of 9.5%[18] Research and Development - Research and development expenses accounted for a significant portion of the company's revenue, indicating a strong focus on innovation and product development[4] - Research and development expenses for the first three quarters of 2025 were ¥105,196,932.27, slightly down from ¥111,278,053.79 in the same period of 2024[18] Market Expansion and Strategy - The company is expanding its overseas operations, particularly in Mexico and the United States, which has contributed to increased production capacity and operational efficiency[8] - The increase in profit margins is attributed to steady growth in various business segments, technological innovations, and improved operational efficiency[9] - The company is actively pursuing new market opportunities and product innovations, which are expected to drive future growth[8] - The company has no significant changes in major shareholders or their holdings during the reporting period[12]

Financial Performance - The company's operating revenue for the third quarter reached ¥86,170,827.01, representing a year-on-year increase of 47.41%[5] - The total profit for the period was a loss of ¥91,109,604.17, with a net profit attributable to shareholders of ¥-86,732,800.64[5] - Total revenue for the first three quarters of 2025 reached ¥216,408,302.14, a significant increase of 55.7% compared to ¥138,951,629.03 in the same period of 2024[21] - Net loss for the first three quarters of 2025 was ¥261,050,841.03, slightly improved from a net loss of ¥271,342,070.94 in the same period of 2024[22] - Basic earnings per share for the first three quarters of 2025 were -¥0.44, compared to -¥0.48 in the previous year[23] Research and Development - Research and development (R&D) expenses amounted to ¥53,359,320.94, which is a decrease of 17.96% compared to the previous year[6] - R&D expenses accounted for 61.92% of operating revenue in the current period, down by 49.34 percentage points year-on-year[6] - Research and development expenses were ¥169,848,302.99, a decrease of 22.4% from ¥219,040,308.86 in the previous year[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,148,699,982.48, a decrease of 3.34% from the previous year[6] - The net assets attributable to shareholders decreased by 11.42% to ¥1,744,502,159.34 compared to the end of the previous year[6] - Total assets decreased to ¥2,148,699,982.48 from ¥2,222,991,903.79, reflecting a decline of 3.3%[19] - Total liabilities increased to ¥412,493,308.25, up from ¥252,618,105.29, marking a rise of 63.4%[19] - The company's equity attributable to shareholders decreased to ¥1,744,502,159.34 from ¥1,969,405,336.09, a decline of 11.4%[19] Cash Flow - The company reported a net cash flow from operating activities of ¥-301,798,901.12 for the year-to-date period[5] - Cash inflow from operating activities for the first three quarters of 2025 reached approximately $216.36 million, a significant increase from $128.58 million in the same period of 2024, representing a growth of about 68.2%[25] - The net cash flow from operating activities was negative at approximately -$301.80 million for 2025, compared to -$325.16 million in 2024, showing an improvement of about 7.1%[26] - The total cash outflow from operating activities was approximately $518.16 million in 2025, compared to $453.74 million in 2024, marking an increase of about 14.2%[26] Investments - Cash inflow from investment activities totaled approximately $4.56 billion in 2025, compared to $3.40 billion in 2024, indicating an increase of about 34.1%[26] - The net cash flow from investment activities was negative at approximately -$60.29 million in 2025, contrasting with a positive $443.76 million in 2024, reflecting a significant decline[26] - The company received approximately $8.07 million from investment in subsidiaries in 2025, while no such income was recorded in 2024[26] - The company reported a cash inflow from the recovery of investments of approximately $4.56 billion in 2025, compared to $3.40 billion in 2024, indicating a strong performance in investment recovery[26] Shareholder Information - The company has a total of 8,667,675 shares in its repurchase account, accounting for 1.52% of total shares[14] - The top shareholder, Pan-Scientific Holdings Co., Ltd., holds 31,858,481 shares, representing a significant portion of the company's equity[14] - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending activities[15] Financial Statements - The financial statements for the quarter are unaudited, indicating that the figures are subject to final review and adjustments[17]

广州方邦电子股份有限公司 2025 年第三季度报告 证券代码：688020 证券简称：方邦股份 广州方邦电子股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | 本报告期 | 本报告期比上 | 年初至报告期 | 年初至报告期末 | | --- | --- | --- | --- | --- | | 项目 | | 年同期增减变 动幅度(%) | 末 | 比上年同期增减 变动幅度(%) | | 营业收入 | 95,964,238.07 | 3.11 | 268,306,110.14 | 11.07 | | 利润总额 | ...

Financial Performance - The company's operating revenue for Q3 2025 was CNY 424,470,623.44, representing a year-on-year increase of 2.67%[4] - The total profit for the period reached CNY 9,941,768.63, a significant increase of 273.79% compared to the same period last year[4] - Net profit attributable to shareholders was CNY 5,978,861.00, up 162.48% year-on-year, while the net profit after deducting non-recurring gains and losses was CNY 5,536,316.03, an increase of 190.64%[4] - The total revenue for the company was CNY 1,183,897,627.30, representing an 11.43% decrease year-over-year, with an overall gross margin of 24.22%[12] - Total operating revenue for the first three quarters of 2025 was ¥1,186,902,173.45, a decrease of 11.43% compared to ¥1,340,673,177.46 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was ¥30,474,636.07, slightly up from ¥29,947,526.30 in 2024, representing an increase of 1.76%[20] - The company achieved a gross profit of ¥19,928,305.84 in the first three quarters of 2025, compared to a gross profit of ¥294,629,217.40 in 2024, indicating a significant decline[19] - The total comprehensive income for the first three quarters of 2025 was ¥10,245,764.13, a decrease from ¥24,167,937.53 in 2024[20] Assets and Liabilities - The company's total assets increased by 7.12% to CNY 3,738,301,973.19 compared to the end of the previous year[5] - As of September 30, 2025, the company's total assets amounted to CNY 3,738,301,973.19, an increase from CNY 3,489,768,020.93 at the end of 2024[14] - The company's current assets totaled CNY 2,198,942,152.62, up from CNY 1,906,060,559.97 at the end of 2024[14] - The total liabilities increased to CNY 2,088,811,617.38 from CNY 1,863,525,871.55 in the previous year[16] - The company's cash and cash equivalents rose to CNY 343,860,135.43, compared to CNY 180,039,805.83 at the end of 2024[14] - Cash and cash equivalents at the end of the first three quarters of 2025 totaled ¥318,713,235.45, compared to ¥329,443,242.18 at the end of the same period in 2024[25] Shareholder Information - The top shareholder, Zhengzhou Tai Rong Industrial Investment Co., Ltd., holds 14.37% of the shares, with 41,220,584 shares pledged[9] - The company has a total of 40,442 common shareholders as of the end of the reporting period[9] Business Segments - The main business segment, pharmaceutical preparations, faced a decline in sales revenue due to incomplete coverage of national traditional Chinese medicine procurement and price reductions[11] - The total revenue for the pharmaceutical preparation segment was CNY 226,792,579.87, a decrease of 37.73% compared to the previous year, with a gross margin of 42.39%[12] - The revenue from traditional Chinese medicine pieces was CNY 611,281,775.45, down 8.75% year-over-year, with a gross margin of 17.22%[12] - The pharmaceutical R&D services generated revenue of CNY 164,566,927.79, reflecting a decline of 25.43% from the previous year, with a gross margin of 34.87%[12] - The pharmaceutical materials circulation segment saw a significant revenue increase of 121.13% to CNY 181,256,344.19, with a gross margin of 15.38%[12] Cash Flow and Financing - The company reported a net cash flow from operating activities of CNY -88,989,041.18, reflecting a decrease of 7.99% year-on-year[4] - The company reported a net cash flow from operating activities of -¥88,989,041.18 for the first three quarters of 2025, an improvement from -¥96,714,807.67 in 2024[24] - The company issued a short-term financing bond totaling CNY 400 million at an annual interest rate of 2.80% on September 25, 2025[13] Research and Development - Research and development expenses for the first three quarters of 2025 were ¥38,101,656.16, a decrease of 50.7% from ¥77,116,859.71 in 2024[19] Earnings Per Share - Basic and diluted earnings per share for the first three quarters of 2025 were both ¥0.0458, down from ¥0.0519 in 2024[20] Investment Income - The company reported an investment income loss of ¥265,270.00 in the first three quarters of 2025, compared to a gain of ¥1,051,330.44 in 2024[19]

北京同益中新材料科技股份有限公司2025 年第三季度报告 证券代码：688722 证券简称：同益中 北京同益中新材料科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 235,859,374.68 | 36.20 | 7 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥940,135,749.83, representing a year-on-year increase of 9.96%[3] - The total profit for the quarter was ¥19,890,612.81, reflecting a growth of 14.02% compared to the same period last year[3] - The net profit attributable to shareholders was ¥16,130,113.00, which is an increase of 22.39% year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥7,704,572.65, showing a significant increase of 108.92% compared to the previous year[3] - The basic earnings per share for the quarter was ¥0.04, up 33.33% from the same period last year[4] - Total operating revenue for the first three quarters of 2025 reached CNY 3,331,120,844.67, an increase of 9.4% compared to CNY 3,044,072,489.89 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 67,355,257.02, compared to CNY 60,210,704.52 in 2024, representing an increase of 11.3%[19] - Earnings per share for the first three quarters of 2025 were CNY 0.16, up from CNY 0.14 in the same period of 2024[20] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was -¥17,666,680.03, indicating a decrease of 90.62% compared to the previous year[3] - Cash inflow from operating activities for the first three quarters of 2025 was CNY 2,388,212,719.53, compared to CNY 2,255,780,460.43 in 2024, indicating a growth of 5.9%[22] - The ending balance of cash and cash equivalents was $590,095,498.76, compared to $529,627,500.05 in the previous period[24] - Total cash outflow from operating activities was $2,405,879,399.56, slightly down from $2,444,047,040.21[23] - Cash paid for employee benefits was $282,013,336.34, compared to $275,144,140.45 in the previous period[23] - Cash paid for taxes was $93,893,861.09, significantly higher than $24,286,802.39 in the previous period[23] - Cash received from investment income was $39,218,455.59, up from $25,849,150.36 in the previous period[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 43,023[9] - The largest shareholder, Anhui Quanchai Group Co., Ltd., holds 82,483,676 shares, accounting for 18.94% of total shares[9] Assets and Liabilities - The company's total liabilities as of the end of the reporting period amounted to CNY 2,913,256,076.29, an increase from CNY 2,844,082,548.85 in the previous year[15] - Total equity attributable to shareholders increased to CNY 3,254,076,271.43 from CNY 3,211,385,083.55, reflecting a growth of 1.3%[15] - The company's total current assets as of September 30, 2025, amount to ¥4,965,019,800.17, an increase from ¥4,647,335,492.30 as of December 31, 2024[12] - Total assets increased to ¥6,198,966,902.19 from ¥6,089,442,774.30[13] Operational Insights - The company reported a significant increase in accounts receivable by 100.91%, primarily due to industry characteristics affecting cash collection[7] - The company experienced a 113.95% increase in prepayments, mainly due to an increase in material payments at the end of the period[7] - There are no other important reminders regarding the company's operational situation during the reporting period[11] - The company aims to expand its market presence and enhance product offerings in the upcoming quarters[16] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 116,492,967.48, slightly up from CNY 115,205,660.32 in 2024[18]

中信重工机械股份有限公司 2025 年第三季度报告 证券代码：601608 证券简称：中信重工 第三季度财务报表是否经审计 □是 √否 审计师发表非标意见的事项 □适用 √不适用 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 1,924,189,533.96 | -3.16 | 5,905,517,183.65 | 0.49 | | 利润总额 | 83,906,152.12 | -9.92 | 291,229,877.82 | 1.21 | | 归属于上市公司股东的净 利润 | 81,711,175.64 | -12.28 | 284,954,624.96 | 0.27 | | 归属于上市公司股东的扣 除非经常性损益的净利润 | 68,184,614.23 | 5.55 | 259, ...